Grammer AG (GMM)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 10.80 |
|---|---|
| 52-week range | 5.40 – 16.40 |
| Return, 1 month / 3 months | −19.4% / +1.9% |
| Return, 1 year / 3 years | +68.8% / −6.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 52.6% |
| Worst drawdown (1 year) | -34.4% |
| Average daily value traded | 0.04M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Grammer AG is a German automotive supplier based in Amberg, Bavaria. It makes seating systems and interior components for passenger cars and commercial vehicles, including seats, armrests, headrests and centre consoles. Its customers are vehicle manufacturers and their suppliers, and it also produces seating for off-road vehicles and trains. The company supplies parts to automotive markets in Europe and other regions, working closely with carmakers on interior fittings and driver and passenger seating.
The shares are listed on the XETRA Stock Exchange in Germany under the code GMM, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Grammer AG (GMM) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 10.80 on 23 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 294 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 68.8% and over the last three months it rose 1.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.4% | ||
| From 52-week high | -33.7% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 1.9% | ||
| 6-month return | 29.3% | ||
| 12-month return, skipping the last month | 109.4% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 52.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.4% | ||
| Liquidity | 33 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.04M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.6% |
|---|---|
| 1 month | −19.4% |
| 3 months | +1.9% |
| 6 months | +29.3% |
| 1 year | +68.8% |
| 3 years | −6.1% |
| 5 years | −46.5% |
Signals
| 50-day / 200-day average | 12.38 / 9.27 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jul 2019 | EUR 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.